Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,872
Total Claims
$1.0M
Drug Cost
379
Beneficiaries
$2,641
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+134%
Cost per patient vs peers
$2,641 vs $1,128 avg
+41%
Brand preference vs peers
11.8% vs 8.4% avg
Brand vs Generic
Brand: 1,747 claims · $806K
Generic: 13,008 claims · $190K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 66 | $83K |
| Semaglutide | 46 | $69K |
| Sitagliptin Phosphate | 92 | $64K |
| Dapagliflozin Propanediol | 85 | $58K |
| Rivaroxaban | 81 | $49K |
| Empagliflozin | 62 | $41K |
| Apixaban | 39 | $30K |
| Tirzepatide | 23 | $27K |
| Fluticasone/Vilanterol | 59 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 37 | $26K |
| Budesonide/Formoterol Fumarate | 37 | $19K |
| Linagliptin | 33 | $19K |
| Liraglutide | 12 | $18K |
| Insulin Detemir | 16 | $17K |
| Lipase/Protease/Amylase | 18 | $16K |
Prescribing Profile
Patient Profile
68
Avg Age
46%
Female
1.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data